Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited) (Parenthetical)

v3.23.2
Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Amortized cost of securities available for sale $ 955,860 $ 978,796
Loans receivable, allowance for credit losses 71,024 71,523
Face amount of subordinated debentures 136,800 136,800
Unamortized discount and debt issuance costs $ 7,092 $ 7,391
Preferred stock par value (in USD per share) $ 0.001 $ 0.001
Preferred stock authorized (shares) 10,000,000 10,000,000
Preferred stock issued (shares) 0 0
Common stock par value (in USD per share) $ 0.001 $ 0.001
Common stock authorized (shares) 62,500,000 62,500,000
Common stock issued (shares) 33,863,421 33,708,234
Common stock outstanding (shares) 30,485,788 30,485,621
Accumulated other comprehensive (loss) income, tax benefit $ (34,571) $ (35,973)
Treasury stock (shares) 3,377,633 3,222,613